Document ID: chunk:federal_register_of_legislation:F2024L00756:reg:9
Version: federal_register_of_legislation:F2024L00756
Segment Type: reg
Provision Reference: reg 9
Character Range: 4357–6775

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, malignant neoplasm of the bile duct or death from malignant neoplasm of the bile duct is connected with the circumstances of a person's relevant service:
(1)          having an infestation of the hepatobiliary tract with the liver flukes Clonorchis sinensis, Opisthorchis viverrini before clinical onset;
(2)          having primary sclerosing cholangitis before clinical onset;
(3)          having inflammatory bowel disease before clinical onset;
(4)          having cholelithiasis, choledocholithiasis or hepatolithiasis before the clinical onset of malignant neoplasm of the bile duct;
Note: Cholelithiasis relates to the formation of stones in the gallbladder, choledocholithiasis relates to stones in the bile ducts, and hepatolithiasis relates to stones in the bile ducts inside the liver.
(5)          having had an injection of Thorotrast (thorium dioxide) before clinical onset;
(6)          having cirrhosis of the liver before clinical onset;
(7)          having chronic infection with the hepatitis B virus at the time of clinical onset;
Note: chronic infection with hepatitis B virus is defined in the Schedule 1 – Dictionary.
(8)          having chronic infection with the hepatitis C virus at the time of clinical onset;
Note: chronic infection with hepatitis C virus is defined in the Schedule 1 – Dictionary.
(9)          having diabetes mellitus for at least 5 years before clinical onset;
(10)      being obese for at least 10 years within the 20 years before clinical onset;
Note: being obese is defined in the Schedule 1 – Dictionary.
(11)      undergoing solid organ transplantation excluding corneal transplant, at least 5 years before clinical onset;
(12)      having non-alcoholic fatty liver disease for at least 5 years within the 20 years before clinical onset;
(13)      consuming at least 640 kilograms of alcohol at least 5 years before clinical onset;
(14)      inhaling, ingesting or having cutaneous contact with 1,2-dichoropropane for at least 1,000 ppm-years at least 5  years before the clinical onset of malignant neoplasm of the bile duct;
Note: ppm-years is defined in the Schedule 1 – Dictionary.
(15)      inability to obtain appropriate clinical management for malignant neoplasm of the bile duct before clinical worsening.